Candriam SCA’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-353,983
| Closed | -$6.73M | – | 849 |
|
|
2021
Q4 | $6.73M | Hold |
353,983
| – | – | 0.04% | 305 |
|
|
2021
Q3 | $11.8M | Hold |
353,983
| – | – | 0.08% | 246 |
|
|
2021
Q2 | $13.7M | Sell |
353,983
-656,244
| -65% | -$25.5M | 0.09% | 238 |
|
|
2021
Q1 | $50.5M | Hold |
1,010,227
| – | – | 0.42% | 53 |
|
|
2020
Q4 | $52.6M | Sell |
1,010,227
-491,262
| -33% | -$25.6M | 0.42% | 53 |
|
|
2020
Q3 | $40.2M | Sell |
1,501,489
-45,582
| -3% | -$1.22M | 0.38% | 56 |
|
|
2020
Q2 | $30.1M | Buy |
1,547,071
+587,098
| +61% | +$11.4M | 0.32% | 74 |
|
|
2020
Q1 | $10.4M | Buy |
959,973
+57
| +0% | +$619 | 0.12% | 205 |
|
|
2019
Q4 | $10.7M | Buy |
+959,916
| New | +$10.7M | 0.11% | 207 |
|
|
2019
Q3 | – | Sell |
-692,000
| Closed | -$5.96M | – | 811 |
|
|
2019
Q2 | $5.96M | Hold |
692,000
| – | – | 0.07% | 292 |
|
|
2019
Q1 | $5.56M | Hold |
692,000
| – | – | 0.07% | 302 |
|
|
2018
Q4 | $2.84M | Hold |
692,000
| – | – | 0.04% | 386 |
|
|
2018
Q3 | $3.88M | Buy |
692,000
+267,000
| +63% | +$1.5M | 0.05% | 374 |
|
|
2018
Q2 | $5.59M | Buy |
425,000
+65,000
| +18% | +$855K | 0.09% | 274 |
|
|
2018
Q1 | $5.11M | Buy |
360,000
+90,000
| +33% | +$1.28M | 0.09% | 279 |
|
|
2017
Q4 | $2.21M | Buy |
270,000
+50,000
| +23% | +$410K | 0.04% | 431 |
|
|
2017
Q3 | $2.61M | Hold |
220,000
| – | – | 0.05% | 401 |
|
|
2017
Q2 | $2.21M | Sell |
220,000
-95,000
| -30% | -$955K | 0.04% | 444 |
|
|
2017
Q1 | $3.67M | Buy |
315,000
+90,000
| +40% | +$1.05M | 0.07% | 322 |
|
|
2016
Q4 | $1.05M | Buy |
225,000
+55,000
| +32% | +$256K | 0.02% | 509 |
|
|
2016
Q3 | $1.32M | Hold |
170,000
| – | – | 0.03% | 443 |
|
|
2016
Q2 | $1.03M | Sell |
170,000
-37,000
| -18% | -$224K | 0.03% | 431 |
|
|
2016
Q1 | $1.75M | Sell |
207,000
-29,200
| -12% | -$247K | 0.04% | 344 |
|
|
2015
Q4 | $2.82M | Sell |
236,200
-25,000
| -10% | -$298K | 0.08% | 259 |
|
|
2015
Q3 | $2.63M | Sell |
261,200
-38,800
| -13% | -$391K | 0.06% | 301 |
|
|
2015
Q2 | $4.98M | Sell |
300,000
-30,000
| -9% | -$498K | 0.1% | 240 |
|
|
2015
Q1 | $5.11M | Sell |
330,000
-50,000
| -13% | -$774K | 0.1% | 250 |
|
|
2014
Q4 | $6.02M | Buy |
+380,000
| New | +$6.02M | 0.13% | 204 |
|